TOMANDLOVÁ, Marie, Martin PISKÁČEK, Vilém JURÁŇ, Marek SOVA, Martin SMRČKA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA a Andrea KNIGHT. Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients. In Brain Tumour Conference 2022, 5-7 September 2022, London. 2022. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{2213743, author = {Tomandlová, Marie and Piskáček, Martin and Juráň, Vilém and Sova, Marek and Smrčka, Martin and Vybíhal, Václav and Fadrus, Pavel and Kazda, Tomáš and Knight, Andrea}, booktitle = {Brain Tumour Conference 2022, 5-7 September 2022, London}, keywords = {PD-L1; B7-H3; galectin-9; plasma levels; glioblastoma}, language = {eng}, title = {Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients}, year = {2022} }
TY - CONF ID - 2213743 AU - Tomandlová, Marie - Piskáček, Martin - Juráň, Vilém - Sova, Marek - Smrčka, Martin - Vybíhal, Václav - Fadrus, Pavel - Kazda, Tomáš - Knight, Andrea PY - 2022 TI - Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients KW - PD-L1 KW - B7-H3 KW - galectin-9 KW - plasma levels KW - glioblastoma N2 - Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients - conference abstract. ER -
TOMANDLOVÁ, Marie, Martin PISKÁČEK, Vilém JURÁŇ, Marek SOVA, Martin SMRČKA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA a Andrea KNIGHT. Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients. In \textit{Brain Tumour Conference 2022, 5-7 September 2022, London}. 2022.
|